TVTX logo

Travere Therapeutics, Inc. (TVTX) Short term debt

Annual short term debt:

$74.08M+$69.17M(+1409.13%)
December 31, 2024

Summary

  • As of today (September 16, 2025), TVTX annual short term debt is $74.08 million, with the most recent change of +$69.17 million (+1409.13%) on December 31, 2024.
  • During the last 3 years, TVTX annual short term debt has risen by +$70.17 million (+1795.68%).
  • TVTX annual short term debt is now at all-time high.

Performance

TVTX Short term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXbalance sheet metrics

quarterly short term debt:

$74.43M+$215.00K(+0.29%)
June 30, 2025

Summary

  • As of today (September 16, 2025), TVTX quarterly short term debt is $74.43 million, with the most recent change of +$215.00 thousand (+0.29%) on June 30, 2025.
  • Over the past year, TVTX quarterly short term debt has increased by +$69.27 million (+1341.66%).
  • TVTX quarterly short term debt is now at all-time high.

Performance

TVTX quarterly short term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXbalance sheet metrics

Short term debt Formula

Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings

TVTX Short term debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+1409.1%+1341.7%
3 y3 years+1795.7%+1705.3%
5 y5 years+2735.2%+5297.6%

TVTX Short term debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+1795.7%at high+1705.3%
5 y5-yearat high>+9999.0%at high>+9999.0%
alltimeall timeat high>+9999.0%at high>+9999.0%

TVTX Short term debt History

DateAnnualQuarterly
Jun 2025
-
$74.43M(+0.3%)
Mar 2025
-
$74.22M(+0.2%)
Dec 2024
$74.08M(+1409.1%)
$74.08M(+0.3%)
Sep 2024
-
$73.90M(+1331.3%)
Jun 2024
-
$5.16M(+2.5%)
Mar 2024
-
$5.04M(+2.6%)
Dec 2023
$4.91M(+10.7%)
$4.91M(+2.7%)
Sep 2023
-
$4.78M(+2.6%)
Jun 2023
-
$4.66M(+2.6%)
Mar 2023
-
$4.54M(+2.5%)
Dec 2022
$4.43M(+13.4%)
$4.43M(+4.7%)
Sep 2022
-
$4.23M(+2.7%)
Jun 2022
-
$4.12M(+2.7%)
Mar 2022
-
$4.01M(+2.7%)
Dec 2021
$3.91M(+994.7%)
$3.91M(+2.8%)
Sep 2021
-
$3.80M(+45.0%)
Jun 2021
-
$2.62M(+140.2%)
Mar 2021
-
$1.09M(+205.9%)
Dec 2020
$357.00K(-86.3%)
$357.00K(-55.3%)
Sep 2020
-
$798.00K(-42.1%)
Jun 2020
-
$1.38M(-43.9%)
Mar 2020
-
$2.46M(-5.9%)
Dec 2019
$2.61M(-88.4%)
$2.61M(-2.1%)
Sep 2019
-
$2.67M(-0.2%)
Jun 2019
-
$2.67M(-89.6%)
Mar 2019
-
$25.59M(+14.0%)
Dec 2018
$22.46M(>+9900.0%)
$22.46M(+0.4%)
Sep 2018
-
$22.38M(-50.7%)
Jun 2018
-
$45.40M(>+9900.0%)
Mar 2018
-
$0.00(0.0%)
Dec 2017
$0.00
$0.00(0.0%)
Sep 2017
-
$0.00(0.0%)
Jun 2017
-
$0.00(0.0%)
DateAnnualQuarterly
Mar 2017
-
$0.00(0.0%)
Dec 2016
$0.00(0.0%)
$0.00(0.0%)
Sep 2016
-
$0.00(0.0%)
Jun 2016
-
$0.00(0.0%)
Mar 2016
-
$0.00(0.0%)
Dec 2015
$0.00(-100.0%)
$0.00(0.0%)
Sep 2015
-
$0.00(-100.0%)
Jun 2015
-
$41.13M(>+9900.0%)
Mar 2015
-
$0.00(-100.0%)
Dec 2014
$40.49M(>+9900.0%)
$40.49M(>+9900.0%)
Sep 2014
-
$0.00(0.0%)
Jun 2014
-
$0.00(-100.0%)
Mar 2014
-
$31.28M(>+9900.0%)
Dec 2013
$0.00(-100.0%)
$0.00(0.0%)
Sep 2013
-
$0.00(0.0%)
Jun 2013
-
$0.00(0.0%)
Mar 2013
-
$0.00(-100.0%)
Dec 2012
$884.80K(+3439.2%)
$884.80K(+3439.2%)
Nov 2011
-
$25.00K(0.0%)
Aug 2011
-
$25.00K(0.0%)
May 2011
-
$25.00K(0.0%)
Feb 2011
$25.00K(+49.7%)
$25.00K(0.0%)
Nov 2010
-
$25.00K(+9.2%)
Aug 2010
-
$22.90K(+15.7%)
May 2010
-
$19.80K(+18.6%)
Feb 2010
$16.70K(>+9900.0%)
$16.70K(+23.7%)
Nov 2009
-
$13.50K(>+9900.0%)
Aug 2009
-
$0.00(0.0%)
May 2009
-
$0.00(0.0%)
Feb 2009
$0.00(0.0%)
$0.00(0.0%)
Nov 2008
-
$0.00(-100.0%)
Aug 2008
-
$25.00K(0.0%)
May 2008
-
$25.00K
Feb 2008
$0.00
-

FAQ

  • What is Travere Therapeutics, Inc. annual short term debt?
  • What is the all time high annual short term debt for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. annual short term debt year-on-year change?
  • What is Travere Therapeutics, Inc. quarterly short term debt?
  • What is the all time high quarterly short term debt for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. quarterly short term debt year-on-year change?

What is Travere Therapeutics, Inc. annual short term debt?

The current annual short term debt of TVTX is $74.08M

What is the all time high annual short term debt for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high annual short term debt is $74.08M

What is Travere Therapeutics, Inc. annual short term debt year-on-year change?

Over the past year, TVTX annual short term debt has changed by +$69.17M (+1409.13%)

What is Travere Therapeutics, Inc. quarterly short term debt?

The current quarterly short term debt of TVTX is $74.43M

What is the all time high quarterly short term debt for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high quarterly short term debt is $74.43M

What is Travere Therapeutics, Inc. quarterly short term debt year-on-year change?

Over the past year, TVTX quarterly short term debt has changed by +$69.27M (+1341.66%)
On this page